10/18/2024

Janusmed sex and gender

Janusmed sex and gender – aminophylline

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
B B
B B

Theophylline

Theophylline

Class : B

Show all info

Print

Contact us

  1. Gardner MJ, Jusko WJ. Effect of age and sex on theophylline clearance in young subjects. Pediatr Pharmacol (New York). 1982;2:157-69.

  2. Driscoll MS, Ludden TM, Casto DT, Littlefield LC. Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models. J Pharmacokinet Biopharm. 1989;17:141-68.

  3. Igarashi T, Iwakawa S. Effect of gender on theophylline clearance in the asthmatic acute phase in Japanese pediatric patients. Biol Pharm Bull. 2009;32:304-7.

  4. Theo-Dur (teofyllin). Summary of Product Characteristics. Medical Products Agency Sweden; 2016.

  5. Bruguerolle B, Toumi M, Faraj F, Vervloet D, Razzouk H. Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics. Eur J Clin Pharmacol. 1990;39:59-61.

  6. Matsuki S, Kotegawa T, Tsutsumi K, Nakamura K, Nakano S. Pharmacokinetic changes of theophylline and amikacin through the menstrual cycle in healthy women. J Clin Pharmacol. 1999;39:1256-62.

  7. Gardner MJ, Schatz M, Cousins L, Zeiger R, Middleton E, Juusko WJ. Longitudinal effects of pregnancy on the pharmacokinetics of theophylline. Eur J Clin Pharmacol. 1987;32:289-95.

  8. Ou-Yang DS, Huang SL, Wang W, Xie HG, Xu ZH, Shu Y et al. Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population. Br J Clin Pharmacol. 2000;49:145-51.

  9. Relling MV, Lin JS, Ayers GD, Evans WE. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther. 1992;52:643-58.

  10. Carrasco-Garrido P, de Miguel-Díez J, Rejas-Gutierrez J, Martín-Centeno A, Gobartt-Vázquez E, Hernandez-Barrera V et al. Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulm Med. 2009;9:2.

  11. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-12-19.]

  1. Gardner MJ, Jusko WJ. Effect of age and sex on theophylline clearance in young subjects. Pediatr Pharmacol (New York). 1982;2:157-69.
  2. Driscoll MS, Ludden TM, Casto DT, Littlefield LC. Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models. J Pharmacokinet Biopharm. 1989;17:141-68.
  3. Igarashi T, Iwakawa S. Effect of gender on theophylline clearance in the asthmatic acute phase in Japanese pediatric patients. Biol Pharm Bull. 2009;32:304-7.
  4. Theo-Dur (teofyllin). Summary of Product Characteristics. Medical Products Agency Sweden; 2016.
  5. Bruguerolle B, Toumi M, Faraj F, Vervloet D, Razzouk H. Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics. Eur J Clin Pharmacol. 1990;39:59-61.
  6. Matsuki S, Kotegawa T, Tsutsumi K, Nakamura K, Nakano S. Pharmacokinetic changes of theophylline and amikacin through the menstrual cycle in healthy women. J Clin Pharmacol. 1999;39:1256-62.
  7. Gardner MJ, Schatz M, Cousins L, Zeiger R, Middleton E, Juusko WJ. Longitudinal effects of pregnancy on the pharmacokinetics of theophylline. Eur J Clin Pharmacol. 1987;32:289-95.
  8. Ou-Yang DS, Huang SL, Wang W, Xie HG, Xu ZH, Shu Y et al. Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population. Br J Clin Pharmacol. 2000;49:145-51.
  9. Relling MV, Lin JS, Ayers GD, Evans WE. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther. 1992;52:643-58.
  10. Carrasco-Garrido P, de Miguel-Díez J, Rejas-Gutierrez J, Martín-Centeno A, Gobartt-Vázquez E, Hernandez-Barrera V et al. Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulm Med. 2009;9:2.
  11. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-12-19.]